Skip to main content

Advertisement

Log in

Atypical presentation of scleroderma in infancy

  • Short Communication
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

We present a case of a female child who had developed progressive skin tightening of whole body, sclerodactyly, and severe contracture of all joints with restricted opening of mouth with disease onset at 6 weeks of life. The child also had anemia, failure to thrive, recurrent diarrhea, and ascites. Skin biopsy revealed characteristic histopathological features suggestive of scleroderma. Echocardiography revealed thrombus in the right atrium extending to inferior vena cava. Serological markers (antinuclear antibody, antiscl 70, anti-double-stranded DNA, anticentromere antibody) were negative. To our knowledge, this case of scleroderma with disease onset at 6 weeks of life could possibly be among youngest cases reported in the literature. Also, thrombosis in inferior vena cava in a child with scleroderma is being reported for the first time.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Zulian F (2008) Systemic Sclerosis and Localized Scleroderma in Childhood. Rheum Dis Clin North Am 34(1):239–255

    Article  PubMed  Google Scholar 

  2. Scalapino K, Arkachaisri T, Lucas M, Fertig N, Helfrich DJ, Londino AV Jr, Steen VD, Medsger TA Jr (2006) Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease. J Rheumatol 33(5):1004–1013

    PubMed  Google Scholar 

  3. Zulian F, Woo P, Athreya BH, Laxer RM, Medsger TA Jr, Lehman TJ, Cerinic MM, Martini G, Ravelli A, Russo R, Cuttica R, de Oliveira SK, Denton CP, Cozzi F, Foeldvari I, Ruperto N (2007) The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis. Arthritis Rheum 57(2):203–212

    Article  PubMed  Google Scholar 

  4. Sato S, Ishida W, Takehara K (2003) A case of juvenile systemic sclerosis with disease onset at six months old. Clin Rheumatol 22(2):162–163

    Article  PubMed  CAS  Google Scholar 

  5. Jansen T, Romiti R (2000) Progeria infantum (Hutchinson-Gilford syndrome) associated with scleroderma-like lesions and acro-osteolysis: a case report and brief review of the literature. Pediatr Dermatol 17(4):282–285

    Article  PubMed  CAS  Google Scholar 

  6. Sevenants L, Wouters C, De Sandre-Giovannoli A, Devlieger H, Devriendt K, van den Oord JJ, Marien K, Lévy N, Morren MA (2005) Tight skin and limited joint movements as early presentation of Hutchinson-Gilford progeria in a 7-week-old infant. Eur J Pediatr 164(5):283–286

    Article  PubMed  Google Scholar 

  7. Silver RM (1991) Clinical aspects of systemic sclerosis (scleroderma). Ann Rheum Dis 50:846–853

    Article  Google Scholar 

  8. Cohen S (1980) The gastrointestinal manifestations of scleroderma: pathogenesis and management (clinical conference). Gastroenterology 79:155–166

    PubMed  CAS  Google Scholar 

  9. Cobden I, Axon AT, Ghoneim AT, McGoldrick J, Rowell NR (1980) Small intestinal bacterial growth in systemic sclerosis. Clin Exp Dermatol 5:37–42

    Article  PubMed  CAS  Google Scholar 

  10. Young MA, Rose S, Reynolds JC (1996) Gastrointestinal manifestation of scleroderma. Rheum Dis Clin North Am 22:797–823

    Article  PubMed  CAS  Google Scholar 

  11. Morel Z, Benadón E, Faugier E, Maldonado MR (2009) Clinical characteristics of children with scleroderma in a referral hospital. Reumatol Clin 5(3):158–162

    Article  PubMed  Google Scholar 

  12. Fennell RHJ, Rodnan GP, Vazquez JJ (1962) Variability of tissue-localizing properties of serum from patients with different disease states. Lab Invest 11:24–31

    Google Scholar 

  13. Beck JS, Anderson JR, Gray KG, Rowell NR (1963) Antinuclear and precipitating autoantibodies in progressive systemic sclerosis. Lancet 2(7319):1188–1190

    PubMed  CAS  Google Scholar 

  14. Solomon DH, Kavanaugh AJ, Schur PH (2002) The American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum 47(4):434–444

    Article  PubMed  Google Scholar 

  15. Martini G, Foeldvari I, Russo R, Cuttica R, Eberhard A, Ravelli A, Lehman TJ, de Oliveira SK, Susic G, Lyskina G, Nemcova D, Sundel R, Falcini F, Girschick H, Lotito AP, Buoncompagni A, Sztajnbok F, Al-Mayouf SM, Orbàn I, Ferri C, Athreya BH, Woo P, Zulian F (2006) Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database. Arthritis Rheum 54(12):3971–3978

    Article  PubMed  CAS  Google Scholar 

  16. Della Rossa A, Valentini G, Bombardieri S, Bencivelli W, Silman AJ, D’Angelo S, Cerinic MM, Belch JF, Black CM, Becvar R, Bruhlman P, Cozzi F, Czirják L, Drosos AA, Dziankowska B, Ferri C, Gabrielli A, Giacomelli R, Hayem G, Inanc M, McHugh NJ, Nielsen H, Scorza R, Tirri E, van den Hoogen FH, Vlachoyiannopoulos PG (2001) European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres. Ann Rheum Dis 60:585–591

    Article  PubMed  CAS  Google Scholar 

  17. Leak A, Patel KJ, Tuddenham EG, Pearson JD, Woo P (1990) Axillary vein thrombosis in adolescent onset systemic sclerosis. Ann Rheum Dis 49(7):557–559

    Article  PubMed  CAS  Google Scholar 

  18. Bonam SR (2006) Isolated renal thrombotic microangiopathy as an initial presentation of scleroderma without other systemic manifestations of the disease. Available on URL:http://www.kidney.org/news/meetings/clinical/pdf/2006SCM-AbstractsTopicList.pdf. Accessed 28 June 2010

  19. Hebbar M, Lassalle P, Delneste Y, Hatron PY, Devulder B, Tonnel AB, Janin A (1997) Assessment of anti-endothelial cell antibodies in systemic sclerosis and Sjogren’s syndrome. Ann Rheum Dis 56:230–234

    Article  PubMed  CAS  Google Scholar 

  20. Ihn H, Sato S, Fujimoto M, Igarashi A, Yazawa N, Kubo M, Kikuchi K, Takehara K, Tamaki K (2000) Characterization of autoantibodies to endothelial cells in systemic sclerosis (SSc): association with pulmonary fibrosis. Clin Exp Immunol 119:203–209

    Article  PubMed  CAS  Google Scholar 

  21. Renaudineau Y, Revelen R, Levy Y, Salojin K, Gilburg B, Shoenfeld Y, Youinou P (1999) Anti-endothelial cell antibodies in systemic sclerosis. Clin Diagn Lab Immunol 6(2):156–160

    PubMed  CAS  Google Scholar 

  22. Assous N, Allanore Y, Batteux F, Meune C, Toulon P, Weill B, Kahan A (2005) Prevalence of antiphospholipid antibodies in systemic sclerosis and association with primitive pulmonary arterial hypertension and endothelial injury. Clin Exp Rheumatol 23(2):199–204

    PubMed  CAS  Google Scholar 

  23. Pope JE, Thompson A (2000) The frequency and significance of anticardiolipin antibodies in scleroderma. J Rheumatol 27:1450–1452

    PubMed  CAS  Google Scholar 

  24. Merkel PA, Chang Y, Pierangeli SS, Convery K, Harris EN, Polisson RP (1996) The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases. Am J Med 101(6):576–583

    Article  PubMed  CAS  Google Scholar 

  25. Ihn H, Sato S, Fujimoto M, Kikuchi K, Igarashi A, Soma Y, Tamaki K, Takehara K (1996) Measurement of anticardiolipin antibodies by ELISA using beta 2-glycoprotein I (beta 2-GPI) in systemic sclerosis. Clin Exp Immunol 105(3):475–479

    Article  PubMed  CAS  Google Scholar 

  26. Herrick AL, Heaney M, Hollis S, Jayson MI (1994) Anticardiolipin, anticentromere and anti-Scl-70 antibodies in patients with systemic sclerosis and severe digital ischaemia. Ann Rheum Dis 53:540–542

    Article  PubMed  CAS  Google Scholar 

  27. Lima J, Fonollosa V, Fernández-Cortijo J, Ordi J, Cuenca R, Khamashta MA, Vilardell M, Simeón CP, Picó M (1991) Platelet activation, endothelial cell dysfunction in the absence of anticardiolipin antibodies in systemic sclerosis. J Rheumatol 18(12):1833–1836

    PubMed  CAS  Google Scholar 

  28. Madej-Pilarczyk A, Rosiska-Borkowska D, Rkawek J, Marchel M, Szalus E, Jablonska S, Hausmanowa-Petrusewicz I (2009) Progeroid syndrome with scleroderma-like skin changes associated with homozygous R435C LMNA mutation. Am J Genet 149(11):2387–2392

    Google Scholar 

  29. Hennekam RC (2006) Hutchinson-Gilford progeria syndrome: review of the phenotype. Am J Med Genet A 140(23):2603–2624

    PubMed  Google Scholar 

  30. Esterly NB, McKusick VA (1971) Stiff skin syndrome. Pediatrics 47:360–369

    PubMed  CAS  Google Scholar 

  31. Jablonska S, Blaszczyk M (2004) Stiff skin syndrome is highly heterogeneous, and congenital fascial dystrophy is its distinct subset. Pediatr Dermatol 21:508–510

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Navin Mishra.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mishra, N., Shrestha, D., Poudyal, R.B. et al. Atypical presentation of scleroderma in infancy. Rheumatol Int 32, 1069–1074 (2012). https://doi.org/10.1007/s00296-011-1803-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-011-1803-4

Keywords

Navigation